Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors

Details for Australian Patent Application No. 2009313167 (hide)

Owner Merck Patent GmbH

Inventors Kellner, Roland; Zenke, Frank; Bomke, Joerg

Agent Davies Collison Cave

Pub. Number AU-A-2009313167

PCT Pub. Number WO2010/051882

Priority 08019432.7 06.11.08 EP

Filing date 5 October 2009

Wipo publication date 14 May 2010

International Classifications

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/051882 Priority application(s): WO2010/051882

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313180-Large screen portable LED display

2009313142-Method for producing an absorbent, disposable incontinence diaper